ONCOLOGY

Anastrozole's intermediates

3,5-Di(2-cyanoisopropyl)-1-bromomethylbenzene

120511-84-4

3,5-Di(2-cyanoisopropyl)-1-hydroxymethyl benzene

120511-88-8

3,5-Di(2-cyanoisopropyl)-1-methylbenzene

120511-72-0

Bendamustine's intermediates

1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester

3543-73-5

1-Methyl-5-nitro-2-benzimidazole butyric acid

31349-48-1

4-{5-[Bis-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazol-2-yl}
-butyric acid ethyl ester

3543-74-6

N-Methyl-4-nitrobenzene-1,2-diamine

41939-61-1

Bicalutamide's intermediates

4-Cyano-3-trifluoromethylaniline

654-70-6

N-(2-Methyl-2,3-epoxypropionyl)-4-cyano-3-trifluoromethylaniline

90357-51-0

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methyl-3
-(4-fluorophenyl)thiopropanamide

90357-06-5

Capecitabine's intermediates

1,2,3-Tri-O-acetyl-5-deoxy-D-ribofuranose

62211-93-2

2’,3’-Di-O-acetyl-5-’deoxy-5-fluorocytidine

161599-46-8

Erlotinib's intermediates

3-Aminophenylacetylene HCl

207726-02-6

6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone

179688-29-0

Imatinib's intermediates

4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid dihydrochloride hemihydrate

106261-49-8

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine

152460-10-1

Pemetrexed disodium's intermediates

4-(2-(2-Amino-4,7-dihydro-4-oxo-1h-pymol(2,3-d)pyrimodin-5-yl)ethyl)benzoic acid

137281-39-1

N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate

165049-28-5